In a recent analysis, the presence of a complex karyotype in AML with an NPM1-mutated gene, with negative or low burden FLT-ITD, was associated with lower response rates and shorter survival despite earlier reports showing no impact on prognosis [71,72,73]. This evidence concerns the gene NPM1 and acute myeloid leukemia.